VIDEO: Stool-based CRC screening promises cost effectiveness

VIDEO: Stool-based CRC screening promises cost effectiveness

In a video exclusive, Paul Limburg, MD, Mayo Clinic, told Healio adherence rates for stool-based colorectal cancer screening and colonoscopy informed comparative effectiveness and the need for improved screening and follow-up adherence.“For our study we took guideline recommended stool-based screening strategies, the multi-target stool DNA test (mt-sDNA), the fecal immunochemical test and fecal occult blood test (FOBT), and inputted data into what’s called the CRC-AIM modeling platform to try to understand using real world data what the outputs would be with respect to the combinationRead More

Share on facebook
Share on twitter
Share on linkedin